Novartis recalls generic Zantac in U.S.
Sandoz is recalling all quantities and lots of its prescription ranitidine capsules.
FDA rejects AZ lung disease treatment
AstraZeneca said the FDA has rejected its new drug application for a COPD therapy.
AstraZeneca said the FDA has rejected its new drug application for a COPD therapy.
Trump almost ready to nominate next FDA commish
The Trump administration is reportedly getting set to nominate a new FDA commissioner.
Novartis’ data manipulation case is a cautionary tale for transparency
“Seeing something and saying something” can be applied to the life sciences.
Pharma’s door to QRM success
The maturation of the cloud makes adoption of proactive quality risk management possible.